Publication | Closed Access

The preoperative SUVmax is superior to ADCmin of the primary tumour as a predictor of disease recurrence and survival in patients with endometrial cancer

Primary TumourTumoral PathologyGynecological SurgeryMedicinePreoperative SuvmaxGynecologyPathologyEndometrial CancerOncologyTumor MicroenvironmentGynecology OncologyCancer ResearchEndocrine-related Cancer